Healthcare

AstraZeneca plcis a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. The company operates across key therapeutic areas including oncology, cardiovascular, renal, metabolism, respiratory, and rare diseases. With a strong global presence and a robust research-driven model, AstraZeneca has …

Genflow Biosciences PLC(LSE:GENF) has moved higher in today’s trading session, reflecting renewed interest in longevity-focused biotechnology companies and gene therapy innovation. As a company developing treatments targeting age-related diseases using gene therapy approaches, LSE:GENF is positioned in a high-growth but high-risk segment of the …

Why is LSE:PRM – Proteome Sciences stock down 17% today on 16 April 2026?

Cambridge Nutritional Sc: iences Plc(LSE:CNSL) has seen an upward movement in its share price today, largely driven by renewed investor focus on the health diagnostics and wellness testing sector. The company operates in a niche but growing market, offering food intolerance and allergy testing …

AstraZeneca PLC(LSE:AZN) is the largest constituent of the FTSE 100 by market capitalisation, with a market value of around 318.9 billion US dollars. The Cambridge-headquartered biopharmaceutical group has become a defining name in global healthcare, with an oncology franchise that ranks among the most …

Nuformix Plchas been gaining attention due to its differentiated business model focused on drug repurposing. Unlike traditional pharmaceutical companies that develop new drugs from scratch, Nuformix leverages existing compounds and enhances them through improved formulations and delivery methods. This approach can reduce development timelines, …

Oxford BioDynamics Plcis a UK-based biotechnology company focused on advancing personalized healthcare through precision diagnostic solutions. The company develops and commercialises molecular diagnostic tests using its proprietary EpiSwitch® 3D genomic platform, which enables detection and prediction of disease and treatment response.